Corporate
Tango Therapeutics Founder Passes Baton as Pivotal Cancer Trial Looms
3d ago
You're signed outSign in or to get full access.
TT
Tango Therapeutics (TNGX)·Earnings Reports
Q3 2025
View earnings summary and analysis
Q2 2025
View earnings summary and analysis
Q1 2025
View earnings summary and analysis
Q4 2024
View earnings summary and analysis
Research analysts covering Tango Therapeutics.